Altered cytoskeletal phosphorylation in mice with altered sterol flux could explain in part why brain diseases such as neurodegenerative disorders, seizures, depression, and even cancer (glioblastoma) could benefit from CYP46A1 activity modulation [4–13]. Here, CYP46A1 is linked to depressive symptom measurement.